Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Filing Date
Sep 26, 2022
Document Date
Sep 26, 2022
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/